Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Specimen Handling 427 Magnetic Resonance Spectroscopy 338 pembrolizumab 262 Biopsy 230 Carboplatin 216 Cisplatin 180 Cyclophosphamide 174 Paclitaxel 148 Nivolumab 136 Gemcitabine 130 Radiotherapy 125 Dexamethasone 105 Bevacizumab 103 Radiation 97 fludarabine 95 Fluorouracil 93 Doxorubicin 90 Pemetrexed 88 Docetaxel 85 Rituximab 83 durvalumab 82 venetoclax 81 Oxaliplatin 81 Leucovorin 76 atezolizumab 70 Prednisone 66 Lenalidomide 66 Capecitabine 66 Etoposide 64 Vincristine 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

apixaban × 30 days × Clear all

NCT04618913 2026-05-26

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡